Advisory Committee on Immunization Practices (ACIP), 7293-7294 [2021-01737]
Download as PDF
<![CDATA[
khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 86, No. 16 / Wednesday, January 27, 2021 / Notices
Growers State Bank, Murdock,
Nebraska.
2. Thomas M. Annesley, Norman,
Oklahoma, as trustee of the Roy T.
Oliver and Rebecca L. Oliver 2020
Irrevocable Trust, Oklahoma City,
Oklahoma, and a member of the Oliver
Family Group; to become the largest
individual shareholder by acquiring
additional voting shares of Valliance
Financial Corp., and thereby indirectly
acquire voting shares of Valliance Bank,
both of Oklahoma City, Oklahoma.
In addition, The Roy T. Oliver and
Rebecca L. Oliver 2020 Irrevocable Trust
to join the Oliver Family Group, a group
acting in concert, by acquiring shares of
Valliance Financial Corp.
3. Larry Adams, Chambers, Nebraska,
individually as the largest shareholder,
as trustee of the Patrick Adams
Testamentary Trust and the S and B
Trust, both of Chambers, Nebraska, and
as a member of the Adams Family
Group, a group acting in concert; to
retain voting shares of Chambanco, Inc.,
and thereby indirectly retain shares of
Chambers State Bank, both of Chambers,
Nebraska.
In addition, Patrick Adams,
individually, the Patrick Adams
Testamentary Trust, and the S and B
Trust, all of Chambers, Nebraska; to join
the Adams Family Group Chambanco,
Inc., and thereby indirectly retain shares
of Chambers State Bank.
B. Federal Reserve Bank of St. Louis
(David L. Hubbard, Senior Manager)
P.O. Box 442, St. Louis, Missouri
63166–2034. Comments can also be sent
electronically to
Comments.applications@stls.frb.org:
1. Carl W. Adams, Jr., Port Charlotte,
Florida, individually and as trustee of
the Carl W. Adams, Jr. Revocable Living
Trust; Curtis Adams, Deborah Adams,
and Caitlyn Adams, all of Quincy,
Illinois; Collin Adams, Iowa City, Iowa;
Craig Adams and his minor children,
Heidi Adams and Jacob Adams, all of
Clive, Iowa; Curt Hilbing and his minor
child, and Crystal Hilbing and her
minor children, all of Quincy, Illinois; to
retain voting shares of First Bankers
Trustshares, Inc., and thereby indirectly
retain voting shares of First Bankers
Trust Company, N.A., both of Quincy,
Illinois.
Board of Governors of the Federal Reserve
System, January 22, 2021.
Michele Taylor Fennell,
Deputy Associate Secretary of the Board.
[FR Doc. 2021–01808 Filed 1–26–21; 8:45 am]
BILLING CODE P
VerDate Sep<11>2014
17:04 Jan 26, 2021
Jkt 253001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors,
National Center for Health Statistics;
Notice of Charter Renewal
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of charter renewal.
AGENCY:
This gives notice under the
Federal Advisory Committee Act of
October 6, 1972, that the Board of
Scientific Counselors, National Center
for Health Statistics, Department of
Health and Human Services, has been
renewed for a 2-year period through
January 19, 2023.
FOR FURTHER INFORMATION CONTACT:
Sayheedha Uddin, M.D., M.P.H.,
Designated Federal Officer, Board of
Scientific Counselors, National Center
for Health Statistics, Department of
Health and Human Services, 3311
Toledo Road, Room 2627, Mailstop P08,
Hyattsville, Maryland 20782, telephone
(301) 458–4303 or fax (301) 458–4020.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
SUMMARY:
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2021–01738 Filed 1–26–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket No. CDC–2021–0008]
Advisory Committee on Immunization
Practices (ACIP)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting and request
for comment.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
SUMMARY:
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
7293
Centers for Disease Control and
Prevention (CDC), announces the
following meeting of the Advisory
Committee on Immunization Practices
(ACIP). This meeting is open to the
public. Time will be available for public
comment. The meeting will be webcast
live via the World Wide Web.
DATES: The meeting will be held on
February 24–25, 2021 from 10:00 a.m. to
5:30 p.m., EST (times subject to change).
Written comments must be received
on or before February 25, 2021.
ADDRESSES: For more information on
ACIP please visit the ACIP website:
https://www.cdc.gov/vaccines/acip/
index.html. You may submit comments,
identified by Docket No. CDC–2021–
0008 by any of the following methods:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Docket No. CDC–2021–0008,
c/o Attn: ACIP Meeting, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H24–8, Atlanta,
GA 30329–4027.
Instructions: All submissions received
must include the Agency name and
Docket Number. All relevant comments
received in conformance with the
https://www.regulations.gov suitability
policy will be posted without change to
https://www.regulations.gov, including
any personal information provided. For
access to the docket to read background
documents or comments received, go to
https://www.regulations.gov.
Written public comments submitted
72 hours prior to the ACIP meeting will
be provided to ACIP members before the
meeting.
FOR FURTHER INFORMATION CONTACT:
Stephanie Thomas, ACIP Committee
Management Specialist, Centers for
Disease Control and Prevention,
National Center for Immunization and
Respiratory Diseases, 1600 Clifton Road,
NE, MS–H24–8, Atlanta, GA 30329–
4027; Telephone: 404–639–8367; Email:
ACIP@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The committee is charged
with advising the Director, CDC, on the
use of immunizing agents. In addition,
under 42 U.S.C. 1396s, the committee is
mandated to establish and periodically
review and, as appropriate, revise the
list of vaccines for administration to
vaccine-eligible children through the
Vaccines for Children (VFC) program,
along with schedules regarding dosing
interval, dosage, and contraindications
to administration of vaccines. Further,
under provisions of the Affordable Care
Act, section 2713 of the Public Health
Service Act, immunization
recommendations of the ACIP that have
E:\FR\FM\27JAN1.SGM
27JAN1
7294
Federal Register / Vol. 86, No. 16 / Wednesday, January 27, 2021 / Notices
khammond on DSKJM1Z7X2PROD with NOTICES
been approved by the Director of the
Centers for Disease Control and
Prevention and appear on CDC
immunization schedules must be
covered by applicable health plans.
Matters To Be Considered: The agenda
will include discussions on cholera
vaccine, hepatitis B vaccine, influenza
vaccines, zoster vaccine, orthopoxvirus
vaccine, pneumococcal vaccine, rabies
vaccine and tickborne encephalitis
vaccine. A recommendation vote on the
rabies vaccine is scheduled. Agenda
items are subject to change as priorities
dictate. For more information on the
meeting agenda visit https://
www.cdc.gov/vaccines/acip/meetings/
meetings-info.html.
Meeting Information: The meeting
will be webcast live via the World Wide
Web; for more information on ACIP
please visit the ACIP website: https://
www.cdc.gov/vaccines/acip/.
Public Participation
Interested persons or organizations
are invited to participate by submitting
written views, recommendations, and
data. Please note that comments
received, including attachments and
other supporting materials are part of
the public record and are subject to
public disclosure. Do not include any
information in your comment or
supporting materials that you consider
confidential or inappropriate for public
disclosure. If you include your name,
contact information, or other
information that identifies you in the
body of your comments, that
information will be on public display.
CDC will review all submissions and
may choose to redact, or withhold,
submissions containing private or
proprietary information such as Social
Security numbers, medical information,
inappropriate language, or duplicate/
near duplicate examples of a mass-mail
campaign. CDC will carefully consider
all comments submitted into the docket.
CDC does not accept comment by email.
Written Public Comment: Written
comments must be received on or before
February 25, 2021. Oral Public
Comment: This meeting will include
time for members of the public to make
an oral comment. Oral public comment
will occur before any scheduled votes
including all votes relevant to the
ACIP’s Affordable Care Act and
Vaccines for Children Program roles.
Priority will be given to individuals
who submit a request to make an oral
public comment before the meeting
according to the procedures below.
Procedure for Oral Public Comment:
All persons interested in making an oral
public comment at the February 24,
2021 ACIP meeting must submit a
VerDate Sep<11>2014
17:04 Jan 26, 2021
Jkt 253001
request at https://www.cdc.gov/vaccines/
acip/meetings/ no later than 11:59 p.m.,
EST, February 18, 2021 according to the
instructions provided.
If the number of persons requesting to
speak is greater than can be reasonably
accommodated during the scheduled
time, CDC will conduct a lottery to
determine the speakers for the
scheduled public comment session.
CDC staff will notify individuals
regarding their request to speak by email
by February 19, 2021. To accommodate
the significant interest in participation
in the oral public comment session of
ACIP meetings, each speaker will be
limited to 3 minutes, and each speaker
may only speak once per meeting.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2021–01737 Filed 1–26–21; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Healthcare Infection Control Practices
Advisory Committee (HICPAC); Notice
of Charter Renewal
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of charter renewal.
AGENCY:
This gives notice under the
Federal Advisory Committee Act of
October 6, 1972, that the Healthcare
Infection Control Practices Advisory
Committee, Department of Health and
Human Services, has been renewed for
a 2-year period through January 19,
2023.
FOR FURTHER INFORMATION CONTACT: KooWhang Chung, M.P.H., HICPAC,
Division of Healthcare Quality
Promotion, National Center for
Emerging and Zoonotic Infectious
Diseases, CDC, 1600 Clifton Road NE,
Mailstop H16–3, Atlanta, Georgia
30329–4027, Telephone: (404) 498–
0730, Email: HICPAC@cdc.gov.
SUMMARY:
Frm 00052
Fmt 4703
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2021–01739 Filed 1–26–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
National Center for Health Statistics
(NCHS), ICD–10 Coordination and
Maintenance (C&M) Committee
Meeting
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
The CDC, National Center for
Health Statistics (NCHS), Classifications
and Public Health Data Standards Staff,
announces the following meeting of the
ICD–10 Coordination and Maintenance
(C&M) Committee meeting. This
meeting is open to the public, limited
only by audio lines available. Online
Registration is not required.
DATES: The meeting will be held on
March 9, 2021, from 9:00 a.m. to 5:00
p.m., EDT, and March 10, 2021, from
9:00 a.m. to 5:00 p.m., EDT.
ADDRESSES: This is a virtual meeting.
Information will be provided on each of
our respective web pages when it
becomes available. For CDC/NCHS
https://www.cdc.gov/nchs/icd/icd10cm_
maintenance.htm. For CMS https://
www.cms.gov/Medicare/Coding/
ICD9ProviderDiagnosticCodes/meetings.
FOR FURTHER INFORMATION CONTACT:
Traci Ramirez, Program Specialist, CDC,
3311 Toledo Road, Hyattsville,
Maryland 20782, Telephone (301) 458–
4454; TRamirez@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The ICD–10 Coordination
and Maintenance (C&M) Committee is a
public forum for the presentation of
proposed modifications to the
International Classification of Diseases,
Tenth Revision, Clinical Modification
and ICD–10 Procedure Coding System.
SUMMARY:
BILLING CODE 4163–18–P
PO 00000
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sfmt 4703
E:\FR\FM\27JAN1.SGM
27JAN1
]]>Agencies
[Federal Register Volume 86, Number 16 (Wednesday, January 27, 2021)]
[Notices]
[Pages 7293-7294]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-01737]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket No. CDC-2021-0008]
Advisory Committee on Immunization Practices (ACIP)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting and request for comment.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the
Centers for Disease Control and Prevention (CDC), announces the
following meeting of the Advisory Committee on Immunization Practices
(ACIP). This meeting is open to the public. Time will be available for
public comment. The meeting will be webcast live via the World Wide
Web.
DATES: The meeting will be held on February 24-25, 2021 from 10:00 a.m.
to 5:30 p.m., EST (times subject to change).
Written comments must be received on or before February 25, 2021.
ADDRESSES: For more information on ACIP please visit the ACIP website:
https://www.cdc.gov/vaccines/acip/. You may submit comments,
identified by Docket No. CDC-2021-0008 by any of the following methods:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments.
Mail: Docket No. CDC-2021-0008, c/o Attn: ACIP Meeting,
Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS
H24-8, Atlanta, GA 30329-4027.
Instructions: All submissions received must include the Agency name
and Docket Number. All relevant comments received in conformance with
the https://www.regulations.gov suitability policy will be posted
without change to https://www.regulations.gov, including any personal
information provided. For access to the docket to read background
documents or comments received, go to https://www.regulations.gov.
Written public comments submitted 72 hours prior to the ACIP
meeting will be provided to ACIP members before the meeting.
FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, ACIP Committee
Management Specialist, Centers for Disease Control and Prevention,
National Center for Immunization and Respiratory Diseases, 1600 Clifton
Road, NE, MS-H24-8, Atlanta, GA 30329-4027; Telephone: 404-639-8367;
Email: [email protected].
SUPPLEMENTARY INFORMATION:
Purpose: The committee is charged with advising the Director, CDC,
on the use of immunizing agents. In addition, under 42 U.S.C. 1396s,
the committee is mandated to establish and periodically review and, as
appropriate, revise the list of vaccines for administration to vaccine-
eligible children through the Vaccines for Children (VFC) program,
along with schedules regarding dosing interval, dosage, and
contraindications to administration of vaccines. Further, under
provisions of the Affordable Care Act, section 2713 of the Public
Health Service Act, immunization recommendations of the ACIP that have
[[Page 7294]]
been approved by the Director of the Centers for Disease Control and
Prevention and appear on CDC immunization schedules must be covered by
applicable health plans.
Matters To Be Considered: The agenda will include discussions on
cholera vaccine, hepatitis B vaccine, influenza vaccines, zoster
vaccine, orthopoxvirus vaccine, pneumococcal vaccine, rabies vaccine
and tickborne encephalitis vaccine. A recommendation vote on the rabies
vaccine is scheduled. Agenda items are subject to change as priorities
dictate. For more information on the meeting agenda visit https://www.cdc.gov/vaccines/acip/meetings/meetings-info.html.
Meeting Information: The meeting will be webcast live via the World
Wide Web; for more information on ACIP please visit the ACIP website:
https://www.cdc.gov/vaccines/acip/.
Public Participation
Interested persons or organizations are invited to participate by
submitting written views, recommendations, and data. Please note that
comments received, including attachments and other supporting materials
are part of the public record and are subject to public disclosure. Do
not include any information in your comment or supporting materials
that you consider confidential or inappropriate for public disclosure.
If you include your name, contact information, or other information
that identifies you in the body of your comments, that information will
be on public display. CDC will review all submissions and may choose to
redact, or withhold, submissions containing private or proprietary
information such as Social Security numbers, medical information,
inappropriate language, or duplicate/near duplicate examples of a mass-
mail campaign. CDC will carefully consider all comments submitted into
the docket. CDC does not accept comment by email.
Written Public Comment: Written comments must be received on or
before February 25, 2021. Oral Public Comment: This meeting will
include time for members of the public to make an oral comment. Oral
public comment will occur before any scheduled votes including all
votes relevant to the ACIP's Affordable Care Act and Vaccines for
Children Program roles. Priority will be given to individuals who
submit a request to make an oral public comment before the meeting
according to the procedures below.
Procedure for Oral Public Comment: All persons interested in making
an oral public comment at the February 24, 2021 ACIP meeting must
submit a request at https://www.cdc.gov/vaccines/acip/meetings/ no later
than 11:59 p.m., EST, February 18, 2021 according to the instructions
provided.
If the number of persons requesting to speak is greater than can be
reasonably accommodated during the scheduled time, CDC will conduct a
lottery to determine the speakers for the scheduled public comment
session. CDC staff will notify individuals regarding their request to
speak by email by February 19, 2021. To accommodate the significant
interest in participation in the oral public comment session of ACIP
meetings, each speaker will be limited to 3 minutes, and each speaker
may only speak once per meeting.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-01737 Filed 1-26-21; 8:45 am]
BILLING CODE 4163-18-P
